Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Cash & Current Investments (2016 - 2026)

Pediatrix Medical (MD) has disclosed Cash & Current Investments for 17 consecutive years, with $499.7 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 43.39% to $499.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $499.7 million through Dec 2025, up 43.39% year-over-year, with the annual reading at $499.7 million for FY2025, 43.39% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $499.7 million at Pediatrix Medical, up from $463.1 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $499.7 million in Q4 2025, with the low at $96.8 million in Q1 2022.
  • Average Cash & Current Investments over 5 years is $250.9 million, with a median of $198.5 million recorded in 2023.
  • The sharpest move saw Cash & Current Investments tumbled 78.84% in 2022, then surged 161.51% in 2025.
  • Over 5 years, Cash & Current Investments stood at $487.1 million in 2021, then crashed by 78.84% to $103.1 million in 2022, then skyrocketed by 72.46% to $177.7 million in 2023, then skyrocketed by 96.07% to $348.5 million in 2024, then skyrocketed by 43.39% to $499.7 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $499.7 million, $463.1 million, and $348.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.